S&P 500 falls on pressure from retail stocks, weak jobless claims
LONDON - ECO Animal Health Group plc (AIM:EAH) announced Thursday that shareholders approved a special resolution at the company’s General Meeting, authorizing trustees of the ECO Animal Health Employee Benefit Trust to begin limited on-market purchases of the company’s ordinary shares.
The veterinary pharmaceutical company, which specializes in antibiotics and vaccines for pigs and poultry, held the General Meeting earlier today where the single special resolution was passed. The resolution specifically allows for the purchase of the company’s ordinary shares with a nominal value of 5 pence each.
The company indicated in its press release statement that voting results from the General Meeting will be made available on its corporate website.
ECO Animal Health describes itself as a global animal health company with operations spanning over 70 countries and a workforce exceeding 200 employees worldwide. The company maintains a portfolio of marketed veterinary products, including its lead product Aivlosin®, a proprietary medication for treating respiratory and intestinal diseases in pigs and poultry.
The company also noted it has a developing research and development pipeline of veterinary pharmaceuticals.
ECO Animal Health Group is dual-listed with Singer Capital Markets serving as its Nominated Adviser and Joint Broker, alongside Investec (LON:INVP) as Joint Broker.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.